Therapeutic Apheresis in Nigeria: A Multi-Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bazuaye Nosa, Okwuonu Chimezie, Idam Evelyn, Adelekan-Popoola Folasade, Gold-Olufadi Shakirat, Kalejaiye Olufunto Olufela, Ogala Abdullateef, Aloziem Zinnah, Amamchukwu Blossom, Elimia Patience, Obot-Obot Mkpoikanabasi, Mbakwe Henry, Maduagwuna Praises, Akinrodoye Olatunji, Anyanwu Chiamaka, Anyanwu Benjamin, Akinsiku Adedamola, Akinsiku Oluwatoyin A, Hassan Muzamil O, Arogundade Fatiu A, Ojo Olalekan E, Weli Homayemem, Adenihun Jesupelumi, Adelaja Aderemi, Bamgboye Ebun, Olatise Olalekan, Faponle Ade E, Odeyemi Ayoola, Muoka Michael, Asaolu Stephen, Busari Qudrat, Dawudu Blessing, Naiyeju Michael, Balogun Rasheed A
Аннотация
METHODS: We present a comprehensive summary of seven oral presentations and three poster abstracts submitted to the inaugural NSFA meeting, representing multi-center experiences from Lagos, southeastern Nigeria, and international collaborative programs.
RESULTS: Collectively, over 3800 therapeutic and donor apheresis procedures were reported across multiple centers over varying time periods. The most common procedures were apheresis platelets (73.7% of 2405 procedures at one center) and automated red cell exchange for sickle cell disease (25.7%). Therapeutic plasma exchange (TPE) was performed for neurological indications including Guillain-Barré syndrome, myasthenia gravis, and neuromyelitis optica, as well as for renal transplant desensitization. A national survey revealed limited awareness among healthcare workers (mean knowledge score 5.10 ± 2.44/10), yet 88.4% expressed interest in hands-on training. International collaboration through the ISN Sister Renal Centers program successfully established TPE capabilities at two centers in southwestern Nigeria. Common challenges included equipment availability, consumables supply, and cost barriers.
CONCLUSIONS: These abstracts demonstrate growing therapeutic and donor apheresis capacity in Nigeria despite significant infrastructural and economic challenges. The establishment of NSFA and collaborative international programs represents a critical step toward expanding access to this essential therapy in West Africa.